Literature DB >> 11583663

Dynamic asymmetries in convergence eye movements under natural viewing conditions.

H Kawata1, K Ohtsuka.   

Abstract

PURPOSE: To clarify differences in the dynamics of convergence eye movements in response to symmetrical stimuli between the dominant eye and the nondominant eye under natural viewing conditions.
METHODS: This study was conducted in 11 normal volunteers (age range, 22-30 years). The subject was seated on a chair, and the head was fixed using a bite-block. The dominant eye was determined with the "hole-in-the-card" test. Horizontal positions of the eyes were recorded using an infrared reflection device. Recordings of right eye movements were subtracted from left eye movements to obtain the vergence response. The fixation target was moved toward the center of both eyes from 50 to 20 cm in front of the face at a constant velocity in five steps (20, 30, 40, 50, and 60 cm/s). The target was moved by a pulse motor controlled by a microcomputer. The dynamic properties of each eye movement and the vergence components were analyzed.
RESULTS: At velocities < or =40 cm/s, convergence responses consisted of two components: the fusion-initiating component and the fusion-sustaining component. The fusion-initiating component drove the initial faster dynamic portion of the response, and the fusion-sustaining component maintained the latter slower dynamic portion of the response. The mean peak velocity of the fusion-initiating component was significantly greater in the dominant eye than in the nondominant eye. The mean peak latency of the catch-up component was significantly shorter in the dominant eye than in the nondominant eye.
CONCLUSIONS: The present study indicated that the trajectory of convergence eye movement under natural viewing conditions consists of two components, the fusion-initiating component and the fusion-sustaining component, and that the convergence response to symmetric stimuli was asymmetric between the dominant eye and the nondominant eye during the fusion-initiating phase. The neural control system of convergence eye movements preferentially drives the dominant eye during the fusion-initiating phase of the response.

Mesh:

Year:  2001        PMID: 11583663     DOI: 10.1016/s0021-5155(01)00405-1

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  7 in total

1.  The horizontal dark oculomotor rest position.

Authors:  Eun H Kim; Tara L Alvarez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-25       Impact factor: 3.117

2.  Comparing accommodative function between the dominant and non-dominant eye.

Authors:  Hamed Momeni-Moghaddam; Colm McAlinden; Abbas Azimi; Mina Sobhani; Eirini Skiadaresi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-26       Impact factor: 3.117

3.  Effect of artificial scotomas on open-loop disparity vergence eye movements.

Authors:  Dongsheng Yang; Richard W Hertle; Mingxia Zhu; Zheng Tai; Eric Hald; Matthew Kauffman
Journal:  Optom Vis Sci       Date:  2015-01       Impact factor: 1.973

4.  Association between Ocular Sensory Dominance and Refractive Error Asymmetry.

Authors:  Feng Jiang; Zheyi Chen; Hua Bi; Edgar Ekure; Binbin Su; Haoran Wu; Yifei Huang; Bin Zhang; Jun Jiang
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

5.  Elucidation of the more myopic eye in anisometropia: the interplay of laterality, ocular dominance, and anisometropic magnitude.

Authors:  Siyu Jiang; Zheyi Chen; Hua Bi; Ruijing Xia; Ting Shen; Ling Zhou; Jun Jiang; Bin Zhang; Fan Lu
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

6.  Cyclopean, Dominant, and Non-dominant Gaze Tracking for Smooth Pursuit Gaze Interaction.

Authors:  Tomer Elbaum; Michael Wagner; Assaf Botzer
Journal:  J Eye Mov Res       Date:  2017-01-25       Impact factor: 0.957

7.  Dominant Eye and Visual Evoked Potential of Patients with Myopic Anisometropia.

Authors:  Qing Wang; Yili Wu; Wenwen Liu; Lin Gao
Journal:  Biomed Res Int       Date:  2016-06-02       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.